Interroll "UBS Evidence Lab inside: Takeaways from the global warehouse..."

Research evidence excerpt

Interroll "UBS Evidence Lab inside: Takeaways from the global warehouse..."

Powered by Lab Global17 JuneResearch2026ab Evidence UBS YES

Interroll Equities

SwitzerlandUBS Evidence Lab inside: Takeaways from the

global warehouse automation survey Industrial, Diversified

12-month rating Buy

12m price target CHF2,295.00Overall investment outlook for warehouse automation remains positive

Our latest UBS Evidence Lab survey on warehouse automation (> Access Dataset) points

towards a constructive investment backdrop, in our view. Spending intentions for the Price (16 Jun 2026) CHF1,400

next 12 months improved further, with the net increase reaching 5.7%, (2025: 5.4%; RIC: INRN.S BBG: INRN SW

2022: 5.9%), while weighted average spending growth rose to 9.6%, hence also above

prior survey levels (2025: 8.7%; 2022: 9.3%). Moreover, the 36-month outlook remains Trading data and key metrics

unchanged from the previous two surveys at 4.2%, with the weighted average growth 52-wk range CHF2,580.00-1,356.00

rate increasing to 6.3%. According to our analysis, the recent UBS Evidence Lab survey Market cap. CHF1.17b/US$1.47b

indicates sustained strong investment appetite in both the near term and medium term. Shares o/s 0.83m (REG)

The broader survey results are addressed in greater depth in our main note. With regard Free float 82%

to Interroll, we consider the survey findings favorable due to the company's targeted Avg. daily volume ('000) 1.91

emphasis on warehouse automation solutions and related services. We rate Interroll Buy. Avg. daily value (m) CHF3

Common s/h equity (12/26E) CHF0.53b

Interroll-specific positives from the survey P/BV (12/26E) 2.2x

(1) Europe, which accounts for around 60% of Interroll's FY25 group top line, continues Net debt to EBITDA (12/26E) NM